Skip to main navigation menu Skip to main content Skip to site footer

Important growth in Latin America concerning approach, diagnosis, and treatment of pulmonary arterial hypertension

Estado actual de la hipertensión pulmonar en 3 países de Latinoamérica y la Sociedad Latina de Hipertensión Pulmonar




Section
Topics review

How to Cite
Important growth in Latin America concerning approach, diagnosis, and treatment of pulmonary arterial hypertension.
rev. colomb. neumol. [Internet]. 2011 Mar. 30 [cited 2024 Dec. 4];23(1):16-21. Disponible en: https://doi.org/10.30789/rcneumologia.v23.n1.2011.171

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Jaime Eduardo Morales Blanhir, MD.
    María de Jesús Rosas Romero, Q.F.B.
      Julio Robledo Pascual, MD.
        Alejandro Londoño V., MD.
          Douglas Olivares Barroeta, MD.

            Jaime Eduardo Morales Blanhir, MD.,

            Internista, Neumólogo. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México. Director del Departamento de Circulación Pulmonar, Asociación Latinoamericana de Tórax (ALAT). Director Médico de la SociedadLatina de Hipertensión Pulmonar (SLHP). Ciudad de México, México.


            María de Jesús Rosas Romero, Q.F.B.,

            Q.F.B. Investigador Asociado A, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.

            Julio Robledo Pascual, MD.,

            Intensivista, Neumólogo. Hospital Regional de Alta Especialidad Dr. Juan Graham Casasús, Villahermosa Tabasco, México.

            Alejandro Londoño V., MD.,

            Internista Neumólogo. Clínica Cardiovascular, Medellín, Colombia.

            Douglas Olivares Barroeta, MD.,

            Neumólogo. Hospital de Clínicas Caracas, Venezuela.

            Migdalia Denis, MD.,

            Presidente, Sociedad Latina de Hipertensión Pulmonar. Estados Unidos.

            In Mexico, patients seek help when the disease is advanced. The working proposal is: to increase the number of referral centers, to increase the availability of new drugs, to improve physician and patient education, and to establish the Diagnosis and Treatment Consensus.

            In Colombia, the Scientific-Technical Committee is developing strategies to diagnose the disease in its early stages, to develop continuing education, and to increase the number of referral centers for different duties. Another idea of the working parties is to encourage patients to carry with them an electronic summary (USB), in case of emergency medical attention.

            In Venezuela, the proposed goals were the following: improved access to drugs, more information to patients, psychological support, helping patients with the expenses.

            In Latin America, Societies of Patients with Pulmonary Hypertension offer impulse to public and private institutions. They should be regarded as an example for development and expansion in other countries, which would have a positive impact on the conditions of life of patients with pulmonary arterial hypertension in Latin America.


            Article visits 1023 | PDF visits 762


            Downloads

            Download data is not yet available.
            1. Chin KM and Rubin LJ: Pulmonary arterial hypertension. J Am Coll Cardiol. 2008; 51(16):1527-38.
            2. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR et al: ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53(17):1573-619
            3. Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T et al: Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 2004;25(24):2243-78.
            4. Badesch D, Champion H, Gomez MA, Hoeper M, Loyd J, Manes A et al: Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S55-66
            5. Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S et al: Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111(23):3105-11
            6. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP et al: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54(1 Suppl): S43-5.
            7. Trow TK, McArdle JR: Diagnosis of pulmonary arterial hypertension. Clin Chest Med 2007; 28(1): 59-73, viii.
            8. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):40S-47S.
            9. Schannwell C, Steiner S, Strauer B. Diagnostics in pulmonary hypertension. J Physiol Pharmacol. 2007; 58 (Suppl 5(Pt 2): 591-602.
            10. Hegewald MJ, Markewitz B, Elliott CG: Pulmonary hypertension: clinical manifestations, classification and diagnosis. Int J Clin Pract Suppl 2007; (156): 5-14.
            11. Tuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA et al: Pulmonary circulation: development and pathology. J Am Coll Cardiol 2009; 54(1 Suppl): S3-9.
            12. Rubin LJ; American College of Chest Physicians: Diagnosis and management of pulmonary arterial hypertension: ACCP Evidencebased clinical practice guidelines. Chest 2004;126(1 Suppl):7S-10S.
            13. Boutet K, Montani D, Jaïs X, Yaïci A, Sitbon O, Simonneau G et al: Therapeutic advances in pulmonary arterial hypertension. Ther Adv Respir Dis 2008; 2(4): 249-65.
            14. Galiè N, Palazzini M, Leci E, Manes A: Current Therapeutic Approaches to Pulmonary Arterial Hypertension. Rev Esp Cardiol 2010; 63(6): 708-724.
            15. Provencher S, Jais X, Yaici A, Sitbon O, Humbert M, Simonneau G: Clinical challenges in pulmonary hypertension: Roger S. Mitchell lecture. Chest 2005; 128(6 Suppl): 622S-628S.
            16. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F et al: Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179(2): 151-7.
            Sistema OJS 3.4.0.7 - Metabiblioteca |